GlassScriptPhysician profile
Milind Parikh
NPI 1194161406
$25,321.68
in general payments reported to CMS, 2019-2025
35 companies · $6,514 in 2025
The $6,514 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $2,266 · 2021: $4,589 · 2022: $3,737 · 2023: $3,748 · 2024: $3,448 · 2025: $6,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,026 · Consulting Fee: $3,575 · Travel and Lodging: $2,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,025.62 |
| Consulting Fee | $3,575.00 |
| Travel and Lodging | $2,108.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,739.32 | 2019-2025 | Mitraclip, Aveir, Jot Dx |
| Heartflow, INC. | $5,397.11 | 2024-2025 | |
| Biotronik INC. | $2,267.53 | 2021-2022 | |
| Boston Scientific Corporation | $2,065.80 | 2019-2025 | Farapulse, Versacross Access Solution, Watchman Access System |
| Edwards Lifesciences Corporation | $1,925.43 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $724.46 | 2020-2024 | Xarelto |
| Shockwave Medical, INC | $579.33 | 2021-2025 | |
| Medtronic, INC. | $568.33 | 2021-2024 | Evera Mri Xt Dr Surescan, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $559.06 | 2020-2023 | Lifevest |
| Aop Health US, LLC | $497.47 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $439.27 | 2022-2025 | |
| Amgen INC. | $387.23 | 2020-2024 | Repatha |
| Astellas Pharma US INC | $323.97 | 2019-2023 | Lexiscan |
| Medtronic Vascular, INC. | $297.59 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $251.28 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $223.56 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $198.93 | 2021-2025 | Verquvo |
| Biosense Webster, INC. | $113.55 | 2021 | |
| Acera Surgical, INC. | $106.95 | 2023 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $106.14 | 2020-2025 | |
| Novo Nordisk INC | $82.76 | 2021-2024 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $77.71 | 2022-2023 | |
| Abiomed | $67.40 | 2022 | |
| Cvrx, INC. | $49.75 | 2022 | |
| Canon Medical Systems USA, INC. | $41.10 | 2023 | Toshiba Scanner |
| Atricure, INC. | $37.46 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $34.18 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $31.54 | 2021-2022 | |
| Reflow Medical INC | $29.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.29 | 2020 | |
| Esperion Therapeutics, INC. | $20.69 | 2021 | |
| Amarin Pharma, INC. | $20.38 | 2020 | |
| Cardiva Medical, INC. | $15.57 | 2021 | |
| Nevro Corp. | $15.55 | 2023 | Senza |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milind Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.